Hjem › Non-Hodgkins lymfom › California › San Francisco
Kliniske studier for Non-Hodgkins lymfom i San Francisco, CA
9 studier for Non-Hodgkins lymfom søker deltakere på steder i og rundt San Francisco (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- og 1 flere
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RekruttererFase 2
- Zuckerberg San Francisco General Hospital, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- UCSF (Peds), San Francisco
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
RekruttererFase 1
- University of California, San Francisco, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Kaiser Permanente-San Francisco, San Francisco
PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, San Francisco
Non-Hodgkins lymfom-studier i andre byer
- New York City, NY31 studier
- Houston, TX31 studier
- Boston, MA26 studier
- Nashville, TN21 studier
- Philadelphia, PA20 studier
- Baldwin Park, CA19 studier
- Washington, DC18 studier
- Chicago, IL18 studier
- Atlanta, GA18 studier
- Milwaukee, WI18 studier
- Columbus, OH18 studier
- Dallas, TX17 studier
Andre studier i San Francisco
- Prostatakreft45 studier
- Brystkreft43 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)35 studier
- Hjertesvikt29 studier
- Metastatisk kreft28 studier
- Lungekreft22 studier
- Melanom22 studier
- Pankreaskreft20 studier
- Eggstokkreft19 studier
- Kolorektal kreft18 studier
- Kardiovaskulær sykdom18 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.